Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway

Bone marrow-derived mesenchymal stem cells (BM-MSCs) are considered to be a potential therapy for end-stage liver disease. However, the therapeutic mechanism of BM-MSCs remains unclear. The aim of the current study was to investigate the role of paracrine signaling in BM-MSCs in liver cirrhosis in v...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, LI-TING, FANG, XUE-QIN, CHEN, QING-FENG, CHEN, HONG, XIAO, PING, PENG, XUE-BIN, ZHANG, SHENG-XIANG, LI, JUN-FENG, MAO, XIAO-RONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626145/
https://www.ncbi.nlm.nih.gov/pubmed/26458849
http://dx.doi.org/10.3892/mmr.2015.4362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626145/
https://www.ncbi.nlm.nih.gov/pubmed/26458849
http://dx.doi.org/10.3892/mmr.2015.4362

Ejemplares similares